Interventional Cardiology

Science News

Time Delay, Infarct Size and Microvascular Obstruction After Primary PCI for ST-Segment Elevation Myocardial Infarction
2020 ACC AHA Guideline for the Management of Patients With Valvular Heart Disease
AHA names top heart disease and stroke research advances of 2020
VIDEO: The American Heart Association Response to the COVID-19 Crisis
Health Equity and Structural Racism Language Guide (PDF)

Journals

Electrocardiographic Strain Pattern Is a Major Determinant of Rehospitalization for Heart Failure After Transcatheter Aortic Valve Replacement
Duration of Hyperemia With Intracoronary Administration of Papaverine
Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long‐Term Outcome
Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta‐Analysis of Contemporary Randomized Controlled Trials
Calcium Modification Techniques in Complex Percutaneous Coronary Intervention

Continuing Education

Registration Now Open

The CVRI Council’s mission is to provide leadership to the AHA to reduce death and disability from cardiovascular, peripheral vascular, and cerebrovascular diseases, using diagnostic and functional imaging and imaging-directed interventions. Council members work to provide outstanding research, education, outreach, and mentorship opportunities.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.


TAVR Low Risk Bicuspid Study | Basel Ramlawi, MD

Co-Principal Investigator Basel Ramlawi, MD summarizes the results of the TAVR Low Risk Bicuspid Study which he presented virtually for ACC 2020. The prospective single-arm interventional study examined TAVR for patients with severe aortic stenosis. See this study and other late-breaking science presentations on our AHA Science News from ACC 2020 page.

American Heart Association Professional Membership

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses